Evidence map›Paper›PMID 42276785›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2026

Nonsteroidal

Vilma I J Jallinoja, Joo Sun Mun, Alexandra Campanella, Aahna Sasson, Teja M Kalidindi, Giovanna Caxeiro, Darren R Veach, Serge Lyashchenko, Heiko Schöder, Naga Vara Kishore Pillarsetty

Abstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Vilma I J JallinojaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Joo Sun MunDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Alexandra CampanellaDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Aahna SassonDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Teja M KalidindiDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Giovanna CaxeiroDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Darren R VeachDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Serge LyashchenkoDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Heiko SchöderDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and.
Naga Vara Kishore PillarsettyDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York; and pillarsn@mskcc.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Androgen receptor (AR) signaling is the key driver of prostate cancer. Thus, standard-of-care treatments focus on androgen-deprivation therapy followed by AR signaling inhibitors. Even when initially responsive, patients eventually develop resistance to therapies targeting AR signaling, leading to disease progression. To study lesion-to-lesion AR occupancy, the radiofluorinated analog of the endogenous androgen [

Indexed as

Fluorine RadioisotopesPositron-Emission TomographyReceptors, AndrogenAnimalsCell Line, TumorDihydrotestosteroneHumansIsotope LabelingMaleMiceProstatic NeoplasmsRadioactive TracersRadiochemistryTissue DistributionDihydrotestosteroneFluorine-18Fluorine RadioisotopesRadioactive TracersReceptors, Androgen18Fandrogen receptorimagingPETprostate cancer

Identifiers

PMID42276785
PMCPMC13544247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.